464 related articles for article (PubMed ID: 14600187)
1. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
Stone GW; McCullough PA; Tumlin JA; Lepor NE; Madyoon H; Murray P; Wang A; Chu AA; Schaer GL; Stevens M; Wilensky RL; O'Neill WW;
JAMA; 2003 Nov; 290(17):2284-91. PubMed ID: 14600187
[TBL] [Abstract][Full Text] [Related]
2. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy.
Tumlin JA; Wang A; Murray PT; Mathur VS
Am Heart J; 2002 May; 143(5):894-903. PubMed ID: 12040355
[TBL] [Abstract][Full Text] [Related]
3. Preventing contrast-induced nephropathy with fenoldopam.
Hunter DW; Chamsuddin A; Bjarnason H; Kowalik K
Tech Vasc Interv Radiol; 2001 Mar; 4(1):53-6. PubMed ID: 11981789
[TBL] [Abstract][Full Text] [Related]
4. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
Stone GW; Tumlin JA; Madyoon H; Lepor NE; McCullough PA; Mathur VS; Murray PT; O'Neill WW
Rev Cardiovasc Med; 2001; 2 Suppl 1():S31-6. PubMed ID: 12439366
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
Allaqaband S; Tumuluri R; Malik AM; Gupta A; Volkert P; Shalev Y; Bajwa TK
Catheter Cardiovasc Interv; 2002 Nov; 57(3):279-83. PubMed ID: 12410497
[TBL] [Abstract][Full Text] [Related]
6. Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial.
Tumlin JA; Finkel KW; Murray PT; Samuels J; Cotsonis G; Shaw AD
Am J Kidney Dis; 2005 Jul; 46(1):26-34. PubMed ID: 15983954
[TBL] [Abstract][Full Text] [Related]
7. Using a dopamine type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy.
Chamsuddin AA; Kowalik KJ; Bjarnason H; Dietz CA; Rosenberg MS; Gomes MD; McDermott CM; Hunter DW
AJR Am J Roentgenol; 2002 Sep; 179(3):591-6. PubMed ID: 12185025
[TBL] [Abstract][Full Text] [Related]
8. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
Huber W; Ilgmann K; Page M; Hennig M; Schweigart U; Jeschke B; Lutilsky L; Weiss W; Salmhofer H; Classen M
Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
[TBL] [Abstract][Full Text] [Related]
9. Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial.
Bove T; Zangrillo A; Guarracino F; Alvaro G; Persi B; Maglioni E; Galdieri N; Comis M; Caramelli F; Pasero DC; Pala G; Renzini M; Conte M; Paternoster G; Martinez B; Pinelli F; Frontini M; Zucchetti MC; Pappalardo F; Amantea B; Camata A; Pisano A; Verdecchia C; Dal Checco E; Cariello C; Faita L; Baldassarri R; Scandroglio AM; Saleh O; Lembo R; Calabrò MG; Bellomo R; Landoni G
JAMA; 2014 Dec; 312(21):2244-53. PubMed ID: 25265449
[TBL] [Abstract][Full Text] [Related]
10. N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.
Briguori C; Colombo A; Airoldi F; Violante A; Castelli A; Balestrieri P; Paolo Elia P; Golia B; Lepore S; Riviezzo G; Scarpato P; Librera M; Focaccio A; Ricciardelli B
J Am Coll Cardiol; 2004 Aug; 44(4):762-5. PubMed ID: 15312855
[TBL] [Abstract][Full Text] [Related]
11. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
[TBL] [Abstract][Full Text] [Related]
12. Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).
Ng TM; Shurmur SW; Silver M; Nissen LR; O'Leary EL; Rigmaiden RS; Cieciorka M; Porter LL; Ineck BA; Kline ME; Puumala SE
Int J Cardiol; 2006 May; 109(3):322-8. PubMed ID: 16039733
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
Barr LF; Kolodner K
Crit Care Med; 2008 May; 36(5):1427-35. PubMed ID: 18434903
[TBL] [Abstract][Full Text] [Related]
14. A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam.
Kini AS; Mitre CA; Kim M; Kamran M; Reich D; Sharma SK
Catheter Cardiovasc Interv; 2002 Feb; 55(2):169-73. PubMed ID: 11835641
[TBL] [Abstract][Full Text] [Related]
15. Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial.
O'Hara JF; Mahboobi R; Novak SM; Bonilla AM; Mascha EJ; Fergany AF; Campbell SC; Kaouk JH; Kaple KM; Gill IS; Ziegman SA; Sessler DI
Urology; 2013 Feb; 81(2):340-5. PubMed ID: 23374797
[TBL] [Abstract][Full Text] [Related]
16. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
[TBL] [Abstract][Full Text] [Related]
17. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study.
Cogliati AA; Vellutini R; Nardini A; Urovi S; Hamdan M; Landoni G; Guelfi P
J Cardiothorac Vasc Anesth; 2007 Dec; 21(6):847-50. PubMed ID: 18068064
[TBL] [Abstract][Full Text] [Related]
18. Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention.
Kini AA; Sharma SK
Rev Cardiovasc Med; 2001; 2 Suppl 1():S19-25. PubMed ID: 12439364
[TBL] [Abstract][Full Text] [Related]
19. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.
Jo SH; Koo BK; Park JS; Kang HJ; Cho YS; Kim YJ; Youn TJ; Chung WY; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2008 Mar; 155(3):499.e1-8. PubMed ID: 18294484
[TBL] [Abstract][Full Text] [Related]
20. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
Ranucci M; Soro G; Barzaghi N; Locatelli A; Giordano G; Vavassori A; Manzato A; Melchiorri C; Bove T; Juliano G; Uslenghi MF
Ann Thorac Surg; 2004 Oct; 78(4):1332-7; discussion 1337-8. PubMed ID: 15464494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
